Yuvraj

Discovery may lead to new treatments for allergic diseases

A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for...

Discovery may lead to new treatments for allergic diseases

A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for...

Advanced research instrumentation pioneer Oxford Optronix launches HypoxyLab™ – the industry’s first benchtop, HEPA-filtered hypoxia workstation

Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of HypoxyLab™...

Promethera Biosciences successfully enrols twenty patients in its multicentric phase I/II trial

Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating twenty patients affected by very rare liver-based metabolic diseases....

Neuroptis Biotech announces the preclinical results for its dry eye product ML7

Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7...

Medtech companies prepare for an innovation makeover

A report by PricewaterhouseCoopers For decades, the medtech industry was on the forefront of innovation, but now return on innovation investment is declining. Growth...

PathoQuest and Covance to offer Next-Generation Sequencing-based biosafety assessments

Covance Inc. , one of the world's largest and most comprehensive drug development companies, and PathoQuest, a pioneer in the field of pathogen detection,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read